Identification of hyponatremia as a risk factor for the development of functional renal insufficiency during converting enzyme inhibition in severe chronic heart failure-Reference-Cited by-同舟云学术

Identification of hyponatremia as a risk factor for the development of functional renal insufficiency during converting enzyme inhibition in severe chronic heart failure

Published:1987-10 Issue:4 Volume:10 Page:837-844
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Packer Milton,Lee Wai Hung,Kessler Paul D.,Medina Norma,Yushak Madeline,Gottlieb Stephen S.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference40 articles.

1. Vasodilator and inotropic therapy for severe chronic heart failure: passion and skepticism;Packer;J Am Coll Cardiol,1983

2. A placebo-controlled trial of Captopril in refractory chronic congestive heart failure;J Am Coll Cardiol,1983

3. Converting-enzyme inhibition for severe chronic heart failure: views from a skeptic;Packer;Int J Cardiol,1985

4. Adverse effects of convertingenzyme inhibition in patients with severe congestive heart failure: pathophysiology and management;Packer;Postgrad Med J,1986

5. Is the renin-angiotensin system really unnecessary in patients with severe chronic heart failure? The price we pay for interfering with evolution (editorial);Packer;J Am Coll Cardiol,1985

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hyponatremia and lower normal serum sodium levels are associated with an increased risk of all‐cause death in heart failure patients;Nursing Open;2023-03-16

2. Effect of renal function on the prognostic importance of chloride in patients with heart failure;Journal of Investigative Medicine;2023-01-20

3. Evaluation of kidney function throughout the heart failure trajectory – a position statement from the Heart Failure Association of the European Society of Cardiology;European Journal of Heart Failure;2020-01-07

4. Identification of immune and metabolic predictors of severe hand-foot-mouth disease;PLOS ONE;2019-05-23

5. Vasopressin in Heart Failure;Endocrine, Metabolic & Immune Disorders - Drug Targets;2018-08-28